Medipal Holdings (7459) · RiskMaterialised

Delays in medical equipment deliveries and sluggish sales due to semiconductor shortages

First written in FY2023-Q1. 1 of 1 entries say "Materialised", first in FY2023-Q1. Latest entry: FY2023-Q1.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Delays in medical equipment deliveries and sluggish sales due to semiconductor shortagesA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

Medipal Holdings moved to the "Worse" side of this theme in 2022.

0 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Not enough years or companies yet to draw the terrain. The sentences above are computed from what exists.

Full recordFilings, disclosures and news, newest first

FY2023-Q1MaterialisedAnnual report
「Revenue slightly exceeded the same period of the previous year, despite delivery delays and sluggish sales of medical devices due to the semiconductor shortage and other factors, because sales increased on higher demand for clinical laboratory reagents and other products related to COVID-19.」
The company stated that the semiconductor shortage actually caused delivery delays and sluggish sales of medical devices. Higher sales resulting from increased demand for clinical laboratory reagents and other products partly offset the impact.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.